Edwards Lifesciences Corp Stock Market Value
EW Stock | USD 86.45 0.79 0.91% |
Symbol | Edwards |
Edwards Lifesciences Corp Price To Book Ratio
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.3 | Revenue Per Share 9.897 | Quarterly Revenue Growth 0.138 | Return On Assets 0.1225 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Edwards Lifesciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Edwards Lifesciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Edwards Lifesciences.
01/20/2024 |
| 04/19/2024 |
If you would invest 0.00 in Edwards Lifesciences on January 20, 2024 and sell it all today you would earn a total of 0.00 from holding Edwards Lifesciences Corp or generate 0.0% return on investment in Edwards Lifesciences over 90 days. Edwards Lifesciences is related to or competes with Agilent Technologies, Illumina, Waters, Thermo Fisher, Mettler Toledo, Charles River, and Guardant Health. Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and ... More
Edwards Lifesciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Edwards Lifesciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Edwards Lifesciences Corp upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 1.33 | |||
Information Ratio | 0.092 | |||
Maximum Drawdown | 12.5 | |||
Value At Risk | (1.86) | |||
Potential Upside | 2.59 |
Edwards Lifesciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Edwards Lifesciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Edwards Lifesciences' standard deviation. In reality, there are many statistical measures that can use Edwards Lifesciences historical prices to predict the future Edwards Lifesciences' volatility.Risk Adjusted Performance | 0.0846 | |||
Jensen Alpha | 0.2015 | |||
Total Risk Alpha | 0.0528 | |||
Sortino Ratio | 0.1404 | |||
Treynor Ratio | 0.3238 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Edwards Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Edwards Lifesciences Corp Backtested Returns
Edwards Lifesciences appears to be very steady, given 3 months investment horizon. Edwards Lifesciences Corp secures Sharpe Ratio (or Efficiency) of 0.12, which denotes the company had a 0.12% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Edwards Lifesciences Corp, which you can use to evaluate the volatility of the firm. Please utilize Edwards Lifesciences' Coefficient Of Variation of 796.11, mean deviation of 1.38, and Downside Deviation of 1.33 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Edwards Lifesciences holds a performance score of 9. The firm shows a Beta (market volatility) of 0.76, which means possible diversification benefits within a given portfolio. As returns on the market increase, Edwards Lifesciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Edwards Lifesciences is expected to be smaller as well. Please check Edwards Lifesciences' potential upside, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether Edwards Lifesciences' price patterns will revert.
Auto-correlation | 0.29 |
Poor predictability
Edwards Lifesciences Corp has poor predictability. Overlapping area represents the amount of predictability between Edwards Lifesciences time series from 20th of January 2024 to 5th of March 2024 and 5th of March 2024 to 19th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Edwards Lifesciences Corp price movement. The serial correlation of 0.29 indicates that nearly 29.0% of current Edwards Lifesciences price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.29 | |
Spearman Rank Test | 0.0 | |
Residual Average | 0.0 | |
Price Variance | 4.88 |
Edwards Lifesciences Corp lagged returns against current returns
Autocorrelation, which is Edwards Lifesciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Edwards Lifesciences' stock expected returns. We can calculate the autocorrelation of Edwards Lifesciences returns to help us make a trade decision. For example, suppose you find that Edwards Lifesciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Edwards Lifesciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Edwards Lifesciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Edwards Lifesciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Edwards Lifesciences stock over time.
Current vs Lagged Prices |
Timeline |
Edwards Lifesciences Lagged Returns
When evaluating Edwards Lifesciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Edwards Lifesciences stock have on its future price. Edwards Lifesciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Edwards Lifesciences autocorrelation shows the relationship between Edwards Lifesciences stock current value and its past values and can show if there is a momentum factor associated with investing in Edwards Lifesciences Corp.
Regressed Prices |
Timeline |
Pair Trading with Edwards Lifesciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edwards Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Edwards Stock
0.81 | ELMD | Electromed | PairCorr |
0.76 | FEMY | Femasys Financial Report 9th of May 2024 | PairCorr |
Moving against Edwards Stock
0.89 | IVP | Inspire Veterinary | PairCorr |
0.73 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
0.65 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
0.51 | DYNT | Dynatronics Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.
The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Edwards Lifesciences Correlation, Edwards Lifesciences Volatility and Edwards Lifesciences Alpha and Beta module to complement your research on Edwards Lifesciences. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Edwards Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.